Bioline Rx Ltd ADR (BLRX)

Überblick Nachrichten Preisverlauf Optionskette Warum fällt BLRX? Forum Prognose Aktiensplit

Warum fällt Bioline Rx Ltd ADR-Aktie (BLRX)?

Wir haben während der Handelssitzung 2024-05-15 einen Rückgang der Aktie Bioline Rx Ltd ADR (BLRX) um 5.26% festgestellt. Obwohl dies auf normale Volatilität oder verschiedene interne und externe Faktoren zurückzuführen sein kann, beachten Sie bitte, dass wir die Situation aktiv beobachten und so schnell wie möglich zeitnahe Updates bereitstellen!

2023-11-20:

Shares of BioLineRx (BLRX) dropped by 10.59% from $1.700 to $1.520 in the trading on Monday, November 20, 2023. The reason why BLRX is down today is due to the company's disappointing Q3 financial results.

Research and development expenses decreased by 37.6%, mainly due to reduced costs associated with NDA supporting activities and the completed AGI-134 clinical trial.
Sales and marketing expenses saw a significant 517.4% increase, driven by heightened pre-commercialization activities.
General and administrative expenses rose by 7.7% due to minor increases in various G&A expenses.
Non-operating expenses surged, primarily due to the revaluation of outstanding warrants caused by an increase in the company's share price.
Net losses for both the three and nine months ended September 30, 2023, were significantly higher compared to the same periods in 2022.